These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9628257)

  • 21. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC; Menter MA
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract]   [Full Text] [Related]  

  • 22. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R; Herborn G
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cirrhosis associated with methotrexate treatment of psoriasis.
    Coe RO; Bull FE
    JAMA; 1968 Nov; 206(7):1515-20. PubMed ID: 5695945
    [No Abstract]   [Full Text] [Related]  

  • 24. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
    Bray AP; Barnova I; Przemioslo R; Kennedy CT
    Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
    [No Abstract]   [Full Text] [Related]  

  • 25. Liver toxicity does not have to follow methotrexate therapy of patients with rheumatoid arthritis.
    Kremer JM
    Am J Gastroenterol; 1997 Feb; 92(2):194-6. PubMed ID: 9040190
    [No Abstract]   [Full Text] [Related]  

  • 26. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
    Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
    Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
    Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
    Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate-induced liver abnormalities in rheumatoid arthritis.
    Bridges SL; Alarcón GS; Koopman WJ
    J Rheumatol; 1989 Sep; 16(9):1180-3. PubMed ID: 2681761
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
    Ezhilarasan D
    Toxicology; 2021 Jun; 458():152840. PubMed ID: 34175381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC
    Ann Dermatol Venereol; 2006; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract]   [Full Text] [Related]  

  • 35. Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.
    van den Reek JMPA; Menting SP; Janssen WWL; Dhaliwal R; Heijboer AC; van Herwaarden AE; Sweep FCGJ; de Jong LM; Tjwa ET; Otero ME; Spuls PI; de Jong EMGJ
    Br J Dermatol; 2017 Nov; 177(5):1454-1457. PubMed ID: 28112796
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.
    Arias JM; Morton KA; Albro JE; Patch GG; Valdivia S; Greenberg HE; Christian PE; Datz FL
    J Nucl Med; 1993 Nov; 34(11):1905-9. PubMed ID: 8229232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current topics in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2011 Jun; 138(6 Suppl 1):H1-5. PubMed ID: 21703467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Update on psoriasis at the Dermatology Day conference, Paris 2010].
    Battistella M; Boulinguez S
    Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H1-10. PubMed ID: 21703456
    [No Abstract]   [Full Text] [Related]  

  • 40. Cirrhosis following prolonged treatment of psoriasis with methotrexate orally.
    Robeson JA; Spenney J; Hirschowitz BI
    South Med J; 1972 Apr; 65(4):453-6. PubMed ID: 5028402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.